Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| 2021-001726-22 | EudraCT Number | ||
| PI19_01005 | Other Grant/Funding Number | Instituto de Salud Carlos III | |
| 2024-513523-16-00 | EU Trial (CTIS) Number |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Spanish Clinical Research Network - SCReN | NETWORK |
| Instituto de Salud Carlos III | OTHER_GOV |
Not provided
Not provided
Not provided
Not provided
The goal of this clinical trial is to compare how two methods for cervical ripening work in a population of singleton pregnancies with late-onset fetal growth restriction (FGR) at term.
The main question it aims to answer is whether Cook´s balloon (a mechanical method) is superior to vaginal dinoprostone (a pharmacological method) in achieving a vaginal delivery, without increasing neonatal morbidity.
Participants will be randomized to receive Cook´s balloon (experimental group) or vaginal dinoprostone (control group) for cervical ripening.
Researchers will compare both groups to see if Cook´s balloon is associated with a higher rate of vaginal delivery than vaginal dinoprostone and is not related to increased neonatal morbidity.
Late-onset fetal growth restriction (FGR) represents the most common subtype of FGR (70-80%). The greatest risk for these fetuses appears once term pregnancy is reached, when stressful situations are added to their status of relative hypoxia, such as the appearance of contractions and funicular compression. Thus, it has been shown that from week 37-38 the risk of intrauterine mortality increases and there is a general consensus not to prolong these pregnancies beyond this period. In this situation, induction of labor is usually preferred over elective caesarean delivery. However, these fetuses have an increased risk of cesarean section for suspected fetal distress.
Mechanical methods for cervical ripening are associated with less uterine stimulation with a lower rate of tachysystole than prostaglandins. Therefore, these methods have been proposed as the optimal approach for late-onset FGR, since they could reduce the rate of cesarean sections for suspected fetal distress. However, there is no published randomized controlled trials on the use of different methods of cervical ripening for labor induction in late-onset FGR.
Thus, the investigators postulate that, in late-onset FGR, cervical ripening with a mechanical method (Cook´s balloon) achieves a higher percentage of vaginal deliveries than a pharmacological method (vaginal dinoprostone), being safe for both the mother and the newborn.
The main aim of this study is to evaluate whether cervical ripening with Cook balloon for labor induction at term gestation of singleton pregnancies with late-onset FGR achieves a higher rate of vaginal delivery compared to the use of vaginal dinoprostone, without increasing neonatal morbidity.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Cook´s balloon | Experimental | Silicone 80 mL double-balloon cervical ripening catheter with an adjustable-length malleable stylet |
|
| Vaginal dinoprostone | Active Comparator | Vaginal delivery system containing 10 mg dinoprostone (Prostaglandin E2) dispersed throughout its matrix and releasing approximately 0.3 mg/hour dinoprostone over a 24-hour period. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Cook´s balloon | Device | Cervical ripening for induction of labor with a mechanical method (Cook´s balloon) |
|
| Measure | Description | Time Frame |
|---|---|---|
| Rate of vaginal delivery | To assess whether cervical ripening with a Cook balloon for induction of labor of term pregnancies with FGR increases the rates of vaginal delivery with respect to the use of vaginal dinoprostone, without increasing neonatal morbidity. | 2 days (from admission to delivery) |
| Measure | Description | Time Frame |
|---|---|---|
| Rate of cesarean sections due to suspected fetal distress | To assess whether cervical ripening with a Cook balloon for induction of labor of term pregnancies with FGR decreases the rates of cesarean sections due to suspected fetal distress with respect to the use of vaginal dinoprostone | 2 days (from admission to delivery) |
Not provided
Inclusion Criteria:
Singleton pregnancy
Age ≥ 18 years
Gestational age (GA) dated by first trimester ultrasound ≥ 37+0 weeks
Cephalic presentation
Stage I fetal growth restriction, defined as the presence of at least one of these two criteria:
Bishop score < 7
Intact fetal membranes
No previous caesarean section
No contraindications for vaginal delivery or labor induction.
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Hospital Sant Joan de Déu | Esplugues de Llobregat | Barcelona | 08950 | Spain | ||
| Hospital Clinic i Provincial |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 39349375 | Derived | Herraiz I, Meler E, Mazarico E, Bonacina E, Blanco JE, Villalain C, Barbero P, Peguero A, Barbera A, Sanchez ML, Llorente Munoz I, Lora Pablos D, Figueras F, Galindo A. Cook's balloon versus dinoprostone for Labour induction of term pregnancies with fetal GROWth restriction: study protocol for a randomised controlled trial in tertiary maternity hospitals in Spain (COLIGROW study). BMJ Open. 2024 Sep 30;14(9):e089628. doi: 10.1136/bmjopen-2024-089628. |
Not provided
Not provided
De-identified IPD that underlies the results reported in the publication will be shared after publications of primary results upon request of investigators whose proposed research has received IRB approval and after data use agreement
From the time of publication and for 5 years thereafter
Upon request of investigators whose proposed research has received IRB approval and after data use agreement
Not provided
Not provided
| ID | Term |
|---|---|
| D005317 | Fetal Growth Retardation |
| ID | Term |
|---|---|
| D005315 | Fetal Diseases |
| D011248 | Pregnancy Complications |
| D005261 | Female Urogenital Diseases and Pregnancy Complications |
| D000091642 | Urogenital Diseases |
Not provided
Not provided
multicenter, randomized (1:1), open-label, 2-arm parallel group, controlled trial
Not provided
Not provided
No masking
Not provided
| Vaginal dinoprostone | Drug | Cervical ripening for induction of labor with a pharmacological method (vaginal dinoprostone) |
|
|
| Induction-to-delivery interval |
Comparison of the time interval between the onset of cervical ripening and delivery between the two arms |
| 2 days (from admission to delivery) |
| Neonatal morbidity | To analyze the neonatal morbidity through the MAIN score (Morbidity assessment index for newborns) of neonatal morbidity and the duration of admissions to the Neonatal Intensive Care Unit (NICU). | From delivery to discharge of the newborn (up to 1 month) |
| Barcelona |
| 08028 |
| Spain |
| Hospital Universitari Vall d'Hebron | Barcelona | 08035 | Spain |
| Hospital Universitario 12 de Octubre | Madrid | 28041 | Spain |
| Hospital Clinico Universitario Virgen de la Arrixaca | Murcia | 30120 | Spain |
| D009358 | Congenital, Hereditary, and Neonatal Diseases and Abnormalities |
| D006130 | Growth Disorders |
| D010335 | Pathologic Processes |
| D013568 | Pathological Conditions, Signs and Symptoms |